Regeneron Pharmaceuticals (NASDAQ:REGN) Reaches New 12-Month Low – Time to Sell?
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) hit a new 52-week low on Thursday . The company traded as low as $784.32 and last traded at $784.95, with a volume of 612102 shares. The stock had previously closed at $804.33. Wall Street Analysts Forecast Growth A number of brokerages have recently weighed in on […]
16 Nov 12:46 · The Cerbat Gem